Skip to main content
SpringerLink
Log in

Health-Related Quality of Life in Patients with Nail Disorders

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Fingernails and toenails are important organs of our body, serving as protection for the tips of fingers and toes. Fingernails also enhance fine touching and tactile sensitivity, as well as aid in the picking up of small objects. Healthy-looking nails are an important part of an individual’s body image, and any nail abnormalities may be considered by patients as a significant cosmetic problem, markedly influencing their self-esteem. However, recent data have indicated that nail lesions are not only important because of cosmetic disfigurement, but may be a symptom of significant morbidity. Severe nail involvement was also shown to negatively impair social functioning and to interfere with work ability, thus markedly influencing a patient’s well-being. Based on literature data and our own experience we conclude that nail diseases cause a marked decrease in health-related quality of life in a substantial percentage of patients. Nail changes are an important medical concern for patients and, therefore, nail diseases should raise attention and receive proper care from both physicians and other healthcare providers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

Similar content being viewed by others

References

  1. Reich A, Szepietowski JC. Quality of life in toenail onychomycosis. In: Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York (NY): Springer, 2010: 3837–50

    Chapter  Google Scholar 

  2. Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009 Sep; 23 (Suppl. 1): 15–21

  3. Moss C, Wong A, Davies P. The Birmingham Epidermolysis Bullosa Severity score: development and validation. Br J Dermatol 2009 May; 160 (5): 1057–65

    Google Scholar 

  4. Szepietowski JC, Reich A, Gaŕowska E, et al. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol 2006 Oct; 142 (10): 1279–84

  5. Reich A, Schwartz RA, Szepietowski JC. Complications of superficial mycoses. In: Fratamico PM, Smith JL, Brogden KA, editors. Sequelae and long-term consequences of infectious diseases. Washington, DC: ASM Press, 2009: 407–13

    Google Scholar 

  6. Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007 Jul; 57 (1): 1–27

  7. Edwards F, de Berker D. Nail psoriasis: clinical presentation and best practice recommendations. Drugs 2009; 69 (17): 2351–61

    Article  PubMed  CAS  Google Scholar 

  8. Williamson L, Dalbeth N, Dockerty JL, et al. Extended report: nail disease in psoriatic arthritis: clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 2004 Jun; 43 (6): 790–4

  9. Radtke MA, Langenbruch AK, Schäfer I, et al. Nail psoriasis as a severity indicator: results fromthe Pso Real study. Patient Relat Outcome Meas 2011; 2: 1–6

    PubMed  Google Scholar 

  10. Baran R. The burden of nail psoriasis: an introduction. Dermatology 2010; 221 Suppl. 1: 1–5

    Article  PubMed  Google Scholar 

  11. Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg 2003 Jul-Aug; 7 (4): 317–21

  12. Lawry M. Biological therapy and nail psoriasis. Dermatol Ther 2007 Jan-Feb; 20 (1): 60–7

  13. Hussain W, Coulson I, Owen C. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients. Clin Exp Dermatol 2008 Jul; 33 (4): 520–2

    Google Scholar 

  14. Gupta AK, Cooper EA. Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg 2009 Sep-Oct; 13 Suppl. 2: S102–6

  15. de Jong EM, Seegers BA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193 (4): 300–3

    Article  PubMed  Google Scholar 

  16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 May; 19 (3): 210–6

    Google Scholar 

  17. Augustin M, Reich K, Blome C, et al. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010 Sep; 163 (3): 580–5

    Google Scholar 

  18. Zimoląg I, Reich A, Szepietowski JC. Influence of psoriasis on the ability to work [abstract no. OP76 plus oral presentation]. Acta Derm Venereol 2009 Sep; 89 (5): 575–6

    Google Scholar 

  19. Rams L, Reich A. Psoriasis in a view of patients: a questionnaire study [in Polish, abstract no. 113]. XIVth Nationwide Conference of Student Scientific Circles of Medical Universities; 2009 Apr 17–18; Wroclaw

  20. Ortonne JP, Baran R, Corvest M, et al. Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol 2010 Jan; 24 (1): 22–7

    Google Scholar 

  21. Warshaw EM, Foster JK, Cham PM, et al. Nail QoL: a quality-of-life instrument for onychomycosis. Int J Dermatol 2007 Dec; 46 (12): 1279–86

    Google Scholar 

  22. Zdrojowy M, Szepietowski J, Zazulak N, et al. Quality of life in nail psoriasis [abstract no. OP25 plus oral presentation]. Acta Derm Venereol 2009 Sep; 89 (5): 561

    Google Scholar 

  23. Zdrojowy M, Szepietowski J, Zazulak N, et al. Creation and validation of Polish version of NailQoL questionnaire [abstract no. OP45]. Acta Derm Venereol 2009 Sep; 89 (5): 566–7

    Google Scholar 

  24. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003 Aug; 49 (2): 206–12

  25. Szepietowski JC, Reich A. Onychomycosis and quality of life. Eur Dermatol 2009; 4 (1): 85–7

    Google Scholar 

  26. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992 Feb; 126 Suppl. 39: 23–7

    Google Scholar 

  27. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995 Nov; 133 (5): 699–703

    Google Scholar 

  28. Gupta AK, Jain HC, Lynde CW, et al. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada: a multicenter survey of 2001 patients. Int J Dermatol 1997 Oct; 36 (10): 783–7

    Google Scholar 

  29. Drake LA, Scher RK, Smith EB, et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol 1998 May; 38 (5 Pt 1): 702–4

    Google Scholar 

  30. Szepietowski JC, Reich A, Pacan P, et al. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire. J Eur Acad Dermatol Venerol 2007 Apr; 21 (4): 491–6

  31. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997 Oct; 36 (10): 754–6

    Google Scholar 

  32. Arrese JE, Piérard-Franchimont C, Piérard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996 Apr; 18 (2): 196–8

    Google Scholar 

  33. Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res 1993 Oct; 2 (5): 341–8

    Google Scholar 

  34. Lubeck DP. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol 1998 May; 38 (5 Pt 3): S64–8

    Google Scholar 

  35. Stewart AL, Ware JE. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham (NC): Duke University Press, 1992

    Google Scholar 

  36. Fleming JS, Courtney BE. The dimensionality of self-esteem II: hierarchical facet model for revised measurement scales. J Pers Soc Psychol 1984; 46: 404–21

    Article  Google Scholar 

  37. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997 Mar; 22 (2): 87–9

  38. Drake L. Qualify of life issues with patients with fungal nail infections. AIDS Patient Care 1995; 9 Suppl. 1: S15–7

    Google Scholar 

  39. Lubeck DP, Gause D, Schein JR, et al. A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual Life Res 1999; 8 (1-2): 121–9

    Article  PubMed  CAS  Google Scholar 

  40. Lubeck DP, Schein JR, Gause D, et al. Health-related quality of life in patients with toenail onychomycosis: data from 9-month observational study. J Clin Outcomes Manage 1999; 6: 37–42

    Google Scholar 

  41. Drake LA, Patrick DL, Fleckman P, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999 Aug; 41 (2 Pt 1): 189–96

    Google Scholar 

  42. Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996 Mar; 34 (3): 220–33

    Google Scholar 

  43. Dupuy HJ. The Psychological General Well-Being index (PGWB). In: Wenger NK, Mattson ME, Furberg CD, et al., editors. Assessment of quality of life in clinical trials of cardiovascular therapies. New York (NY): Le Jacq Publishing, 1984: 170–83

    Google Scholar 

  44. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 2000 Feb; 9 (1): 39–53

    Google Scholar 

  45. Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatol Treat 2003 Jun; 14 (2): 95–8

    Google Scholar 

  46. Potter LP, Mathias SD, Raut M, et al. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes 2006 Aug; 4: 50

    Google Scholar 

  47. Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997 Nov; 133 (11): 1433–40

  48. Szepietowski JC, Reich A, Woźniak M, et al. Evaluation of quality of life in patients with onychomycosis using the Polish version of Dermatology Life Quality Index. Mikol Lek 2006; 13 (3): 193–8

    Google Scholar 

  49. Szepietowski JC, Reich A, Wesőowska-Szepietowska E, et al. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses 2009; 52 (4): 357–63

    Article  PubMed  Google Scholar 

  50. Katsambas A, Abeck D, Haneke E, et al. The effects of foot disease on quality of life: results of the Achilles Project. J Eur Acad Dermatol Venereol 2005 Mar; 19 (2): 191–5

  51. Szepietowski JC, Reich A; for the National Quality of Life in Dermatology Group. Stigmatisation in onychomycosis patients: a population-based study. Mycoses 2008; 52 (4): 343–9

    Article  PubMed  Google Scholar 

  52. Kowalczuk-Zieleniec E, Nowicki E, Majkowicz M. Onychomycosis changes quality of life [abstract no. P23-20]. J Eur Acad Dermatol Venereol 2002; 16 Suppl. 1: 248

    Google Scholar 

  53. Millikan LE, Powell DW, Drake LA. Quality of life for patients with onychomycosis. Int J Dermatol 1999 Sep; 38 Suppl. 2: 13–6

    Google Scholar 

  54. Lateur N. Onychomycosis: beyond cosmetic distress. J Cosmet Dermatol 2006 Jun; 5 (2): 171–7

  55. Tabolli S, Alessandroni L, Gaido J, et al. Health-related quality of life and nail disorders. Acta Derm Venereol 2007; 87 (3): 255–9

    PubMed  Google Scholar 

  56. Gilbar P, Hain A, Peereboom VM. Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract 2009 Sep; 15 (3): 143–55

  57. Hong J, Park SH, Choi SJ, et al. Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer. Jpn J Clin Oncol 2007 Jun; 37 (6): 424–8

  58. Winther D, Saunte DM, Knap M, et al. Nail changes due to docetaxel: a neglected side effect and nuisance for the patient. Support Care Cancer 2007 Oct; 15 (10): 1191–7

    Google Scholar 

  59. van de Kerkhof PC, Pasch MC, Scher RK, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol 2005 Oct; 53 (4): 644–51

  60. Scher RK. Brittle nails. Int J Dermatol 1989 Oct; 28 (8): 515–6

Download references

Acknowledgments

This work was supported by the educational grant ST-374 of Wroclaw Medical University. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 1 50-368, Ul. Chalubinskiego, Wroclaw, Poland

    Adam Reich &  Jacek C. Szepietowski

Authors
  1. Adam Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacek C. Szepietowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacek C. Szepietowski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reich, A., Szepietowski, J.C. Health-Related Quality of Life in Patients with Nail Disorders. Am J Clin Dermatol 12, 313–320 (2011). https://doi.org/10.2165/11592120-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11592120-000000000-00000

Keywords

Search

Navigation